CLINICAL_TRIALS trial_result · 2021-05-13

Clinical Trial Update: First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

Phase 2 trial update on first-line chemotherapy for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-05-13